Evolva Holding SA
SIX:EVE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Evolva Holding SA
Total Liabilities & Equity
Evolva Holding SA
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Evolva Holding SA
SIX:EVE
|
Total Liabilities & Equity
CHf7.1m
|
CAGR 3-Years
-63%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
-28%
|
|
|
Sika AG
F:SIKA
|
Total Liabilities & Equity
CHf15.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
12%
|
|
|
Givaudan SA
SIX:GIVN
|
Total Liabilities & Equity
CHf11.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
7%
|
|
|
Ems Chemie Holding AG
SIX:EMSN
|
Total Liabilities & Equity
CHf2.2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
|
Dottikon Es Holding AG
SIX:DESN
|
Total Liabilities & Equity
CHf1.4B
|
CAGR 3-Years
12%
|
CAGR 5-Years
21%
|
CAGR 10-Years
15%
|
|
|
D
|
DSM-Firmenich AG
AEX:DSFIR
|
Total Liabilities & Equity
€29.3B
|
CAGR 3-Years
19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Evolva Holding SA
Glance View
Evolva Holding SA is a biotech company, which engages in the research, development, manufacture, and commercialization of nutritional, healthcare, and wellness ingredients. The company is headquartered in Reinach, Basel-Landschaft and currently employs 68 full-time employees. The company went IPO on 2005-05-04. The activity of the Company is divided into two segments: technololgy platforms - combines biology with technology to produce nature-based ingredients; technology servises- provides tailored services to clients across industries. The firm is focused on developing and increase the yield and efficiency of the production of various ingredients.
See Also
What is Evolva Holding SA's Total Liabilities & Equity?
Total Liabilities & Equity
7.1m
CHF
Based on the financial report for Jun 30, 2025, Evolva Holding SA's Total Liabilities & Equity amounts to 7.1m CHF.
What is Evolva Holding SA's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
-28%
Over the last year, the Total Liabilities & Equity growth was -11%. The average annual Total Liabilities & Equity growth rates for Evolva Holding SA have been -63% over the past three years , -47% over the past five years , and -28% over the past ten years .
